Blue Jet Healthcare
NSE: BLUEJET · ISIN INE0KBH01020 · Healthcare
₹549.20−20.75 (−3.64%)
Monday 9 November, 12:47 IST. Delayed. Source: Yahoo Finance.
Price chart
₹549.20 −20.75 (−3.64%) today
The day
- Previous close
- ₹569.95
- Open
- ₹571.75
- Day high
- ₹571.75
- Day low
- ₹544.05
Listed on NSE since 1 November 2023.
Key numbers
- Market value
- ₹9,886.66 Cr
- P/E (trailing)
- 35.56
- EPS (trailing)
- ₹16.03
- Price to book
- 4.66
- Dividend yield
- 0.22%
- Return on equity
- 16.1%
- Debt to equity
- 0.02
- Profit margin
- 25.8%
- Volume today
- 4.65 L
- Average volume
- 5.89 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹720.53 Cr | ₹160.03 Cr |
| FY24 | ₹710.32 Cr | ₹163.75 Cr |
| FY25 | ₹1,026.10 Cr | ₹305.20 Cr |
| FY26 | ₹944.43 Cr | ₹247.82 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹376 Cr | ₹103 Cr | +96.6% |
| Q1 FY27Apr–Jun 2026 | ₹293 Cr | ₹78 Cr | −14.2% |
| Q4 FY26Jan–Mar 2026Audited | ₹235 Cr | ₹64 Cr | −41.6% |
| Q3 FY26Oct–Dec 2025 | ₹192 Cr | ₹40 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹165 Cr | ₹52 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹355 Cr | ₹91 Cr | – |
Source: Blue Jet Healthcare’s results filed with NSE, standalone (the company alone). Net profit is the share of Blue Jet Healthcare’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹684 Cr | ₹616 Cr |
| Investments | ₹675 Cr | ₹252 Cr |
| Inventories | ₹251 Cr | ₹187 Cr |
| Owed by customers | ₹445 Cr | ₹339 Cr |
| Cash and equivalents | ₹77 Cr | ₹61 Cr |
| Total assets | ₹2,584 Cr | ₹1,641 Cr |
| Borrowings | ₹0 | ₹0 |
| Total liabilities | ₹285 Cr | ₹281 Cr |
| Shareholders’ equity | ₹2,299 Cr | ₹1,360 Cr |
Source: Blue Jet Healthcare’s half-yearly statements of assets and liabilities filed with NSE, standalone. Companies file these every September and March.
About Blue Jet Healthcare
Blue Jet Healthcare Limited engages in the manufacturing and sale of artificial sweeteners, pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in products. It provides contrast media intermediates, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related supplies to healthcare, pharma, animal feed, and food and beverages industries. It has operations in India, Norway, France, the United States, Denmark, Thailand, Spain, Italy, Sweden, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India.
- Industry
- Biotechnology
- Based in
- Thane
- Employees
- 581
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Blue Jet Healthcare in the last day or two.
Dividends and corporate actions
All companies- Dividend - Rs 1.20 Per Share
Dividend · ex-date 11 September 2026 · record date 14 September 2026
- Dividend - Rs 1.20 Per Share
Dividend · ex-date 19 September 2025
- Annual General Meeting
Action · ex-date 17 September 2024
- Dividend - Re 1 Per Share
Dividend · ex-date 17 September 2024 · record date 18 September 2024
Source: NSE. Latest first.
Information only, not investment advice. Prices are delayed.